The Role of Sphingolipids in Myocardial Recovery Mediated by Mechanical Unloading and Circulatory Support

Myocardial recovery after left ventricular assist device (LVAD) support is a critical phenomenon that allows advanced heart failure patients to retain their native heart. We quantified targeted sphingolipids in serum and cardiac tissue of patients who exhibited recovery post-LVAD. Our analysis revealed sustained elevated circulating ceramides levels in nonresponders post-LVAD, whereas responders showed reduced sphingosine-1-phosphate (S1P) levels. In contrast, cardiac tissue from nonresponders displayed increased S1P levels. We suggest that diminished ceramide and S1P may contribute to an increased likelihood of recovery after LVAD support. Collectively, our findings implicate the sphingolipid metabolic pathway as a potential therapeutic target to promote myocardial recovery after mechanical support.

Authors

Institutions

Publication Details

Journal
JACC Basic to Translational Science
Published
2025-12-19
DOI
https://doi.org/10.1016/j.jacbts.2025.101435
Primary Topic
Sphingolipid Metabolism and Signaling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Role of Sphingolipids in Myocardial Recovery Mediated by Mechanical Unloading and Circulatory Support

Joseph R. Visker, Matthew T. Rondina, Scott A. Summers, Rami Alharethi et al.
JACC Basic to Translational Science
Sphingolipid Metabolism and Signaling
article

The Role of Sphingolipids in Myocardial Recovery Mediated by Mechanical Unloading and Circulatory Support

Joseph R. Visker, Matthew T. Rondina, Scott A. Summers, Rami Alharethi, James C. Fang, William L. Holland, Elizabeth Dranow, Craig H. Selzman, Ling Jing, J. Alan Maschek, Konstantinos Sideris, Stavros G. Drakos, Josef Stehlik, Sean M. Tatum, Sutip Navankasattusas, TingTing Hong, Rana Hamouche, Christos P. Kyriakopoulos, Thirupura S. Shankar, Eleni Tseliou, Abdallah G. Kfoury
article en

Abstract

Myocardial recovery after left ventricular assist device (LVAD) support is a critical phenomenon that allows advanced heart failure patients to retain their native heart. We quantified targeted sphingolipids in serum and cardiac tissue of patients who exhibited recovery post-LVAD. Our analysis revealed sustained elevated circulating ceramides levels in nonresponders post-LVAD, whereas responders showed reduced sphingosine-1-phosphate (S1P) levels. In contrast, cardiac tissue from nonresponders displayed increased S1P levels. We suggest that diminished ceramide and S1P may contribute to an increased likelihood of recovery after LVAD support. Collectively, our findings implicate the sphingolipid metabolic pathway as a potential therapeutic target to promote myocardial recovery after mechanical support.

JACC Basic to Translational ScienceVol. 11(1)
University of Utah (US), Utah Cancer Specialists (US)
Openalex Percentile: Top 63%
Sphingolipid Metabolism and Signaling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.